MiNK Therapeutics (INKT)

• Market cap: $58.9M
• 1 day: -2.26%
• 5 days: 3.12%
• 1 month: 3.47%
• 3 months: -11.69%
• 6 months: -32.98%
• Year to date: 12.77%
• 1 year: 127.59%
• 5 years: -89.55%
• 10 years: -89.55%
• Sector: Healthcare
• Industry: Biotechnology

About: MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Employees: 23